LP3 Network Free Webinar - Veterinary Compounding, A Customized Approach

Download in electronic PDF format for $25



Search the Complete Journal Archives

Is Veterinary Compounding Illegal Under Federal Law?

Author(s):  Gibbs Jeffrey N

Issue:  Nov/Dec 2004 - Endotoxin
View All Articles in Issue

Abstract:  The United States Food and Drug Administration (FDA) has taken the position that all pharmaceutical compounding is illegal under the Federal Food, Drug, and Cosmetic Act. The FDA has said that it will exercise its discretion to allow compounding to fill valid prescriptions, but it has conditioned this right to compound on pharmacies meeting criteria that the FDA has developed. A review of legislative and judicial actions on compounding indicate that the FDA is wrong, because Congress has never banned compounding.

Related Keywords: Jeffrey N. Gibbs, BA, JD, US Food and Drug Administration, FDA, Federal Food, Drug, and Cosmetic Act, FDC Act, good manufacturing practice, GMP

Related Categories: LEGAL, VETERINARY, FDA

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample
Is Veterinary Compounding Illegal Under Federal Law? Gibbs Jeffrey N Nov/Dec 2004 449-450 Buy
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr Nov/Dec 2015 487-488 Buy
Compounding OTC Drugs: A Legal Perspective Gibbs Jeffrey N, Mazan Kate Duffy May/Jun 2000 180 Buy
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G Jul/Aug 2015 303-305 Buy
Drugs Banned for Use in Food Animals: An Explanation Davidson Gigi S Mar/Apr 2001 101 Buy
Standing Together Fixing the Drug Quality and Security Act Miller David G Mar/Apr 2015 104-106 Buy
U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013 Miller David G Jan/Feb 2014 35-36 Buy
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake Sep/Oct 2015 377-380 Buy
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Allen Loyd V Jr Sep/Oct 2015 389-390 Buy